Myelodysplastic syndrome differential diagnosis

	Myelodysplastic syndrome Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Myelodysplastic syndrome from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
Echocardiography and Ultrasound
CT
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Myelodysplastic syndrome differential diagnosis On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Myelodysplastic syndrome differential diagnosis All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Myelodysplastic syndrome differential diagnosis
CDC on Myelodysplastic syndrome differential diagnosis
Myelodysplastic syndrome differential diagnosis in the news
Blogs on Myelodysplastic syndrome differential diagnosis
Directions to Hospitals Treating Myelodysplastic syndrome
Risk calculators and risk factors for Myelodysplastic syndrome differential diagnosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Nawal Muazam M.D.[2] Amandeep Singh M.D.[3]

Overview

Myelodysplastic syndrome must be differentiated from other diseases that cause anemia, neutropenia, and thrombocytopenia, such as: aplastic anemia, fanconi anemia, pure red cell aplasia, Shwachman-Diamond syndrome, paroxysmal nocturnal hemoglobinuria, parovirus B19 infection, and vitamin B12 defeciency

Myelodysplastic syndrome differential diagnosis

Myelodysplastic syndrome must be differentiated from other diseases that cause anemia, neutropenia, and thrombocytopenia, such as: aplastic anemia, fanconi anemia, pure red cell aplasia, Shwachman-Diamond syndrome, paroxysmal nocturnal hemoglobinuria, parovirus B19 infection, and vitamin B12 defeciency.^[1]^[2]^[3]^[4]


Inherited cytopenia	Acquired cytopenia	Reactive cytopenia

Aplastic anemia Fanconi anemia Pure red cell aplasia Shwachman-Diamond syndrome Large granular lymphocytosis Congenital hematopoietic disorder Congenital dyserythropoietic anemia	Paroxysmal nocturnal hemoglobinuria Parovirus B19 infection Myeloproliferative neoplasm Toxic exposures Biologic agents Heavy metals Chemotherapy	Nutritional deficiency Vitamin B12 defeciency Folate defeciency Infections

It includes the differentiating from the causes of thrombocytopenia and macrocytic anemia when it requires following differentials:

Differentiation from other causes of Macrocytic anemia

Disease	Genetics	Clinical manifestation					Lab findings
		History	Symptoms	Signs	Hemolysis	Intrinsic/Extrinsic	Hb concentration	MCV	RDW	Reticulocytosis	Haptoglobin levels	Hepcidin	Iron studies					Specific finding on blood smear
		History	Symptoms	Signs	Hemolysis	Intrinsic/Extrinsic	Hb concentration	MCV	RDW	Reticulocytosis	Haptoglobin levels	Hepcidin	Serum iron	Serum Tfr level	Transferrin or TIBC	Ferritin	Transferrin saturation	Specific finding on blood smear
Folate deficiency^[5]	Impaired DNA synthesis	Alcohol consumption History of using drugs like methotrexate, trimethoprim, and phenytoin Low socioeconomic groups with poor nutrition Older people Pregnant and lactating women	No neurological symptoms vs B12 deficiency Odynophagia Angular stomatitis	Glossitis Signs of heart failure Anencephaly and spina bifida	−	−	Anisochromic	Macrocytic	↑	↓	Nl	Nl	↑	↑	↓	↑	↑	RBC macrocytosis Hypersegmented neutrophils Pancytopenia in severe cases
Vitamin B12 deficiency^[6]	Impaired DNA synthesis	Pernicious anemia Crohn's disease Gastrectomy Veganism Diphyllobothrium latum infection	Psychosis Insomnia Depression Cognitive slowing Restless leg syndrome	Neurological deficit Myelopathy Memory loss with reduced attention span Nystagmus Positive romberg sign Positive Lhermitte's sign	−	−	Anisochromic	Macrocytic	↑	↓	Nl	Nl	↑	↑	↓	↑	↑	Senile neutrophil Anisocytosis Ovalocytes
Orotic aciduria^[7]	Autosomal recessive Deficiency of enzyme UMPS	Episodic vomiting Rhabdomyolysis	Coma Gastrointestinal manifestation	Neurological manifestation	−	−	Anisochromic	Macrocytic	↑	↓	Nl	Nl	↑	↑	↓	↑	↑	NA
Fanconi anemia^[8]	Autosomal recessive X-linked recessive	History of anemia at age 16	Hypopigmentation Cafe-au-lait patches Radial ray anomaly	Significant for bilateral short thumbs	−	−	Anisochromic	Macrocytic	↑	↓	Nl	Nl	↑	↑	↓	↑	↑	Nl appearing WBC, RBC and Platelets But the number is greatly reduced
Disease	Genetics	History	Symptoms	Signs	Hemolysis	Intrinsic/Extrinsic	Hb concentration	MCV	RDW	Reticulocytosis	Haptoglobin levels	Hepcidin	Serum iron	Serum Tfr level	IBC	Ferritin	Transferrin saturation	Specific finding on blood smear
Diamond-Blackfan anemia^[9]	Mutations in: RPL5 RPL11 RPL35A RPS7 RPS10 RPS17 RPS19 RPS24 RPS26	Associated with myelodysplastic syndrome Increased risk of AML	Pale skin Sleepiness Heart murmurs	Triphalangeal thumbs Short stature Microcephaly Hypertelorism Ptosis Micrognathia	−	−	Anisochromic	Macrocytic	Nl	↓	Nl	Nl	↑	↑	↓	↑	↑	NA
Liver disease^[10]	−	Hepatitis Binge drinking Gall bladder disease	Jaundice Abdominal pain Itchy skin	Ascites Right upper quadrant pain Hepatomegaly Swelling in the legs Ankle swelling	−	−	Anisochromic	Macrocytic	↑	↑	Nl	Nl	↑	↑	↓	↑	↑	Round macrocytes Target macrocytes
Alcoholism^[11]	−	History of increased alcohol intake Folic acid deficiency	Memory impairment Nausea Sweating	Truncal obesity Asterixis Encephalopathy Spider angiomas Hematemesis Gynecomastia	−	−	Anisochromic	Macrocytic	↑	↑	Nl	Nl	↑	↑	↓	↑	↑	Oval macrocytes Hypersegmented neutrophils
Disease	Genetics	History	Symptoms	Signs	Hemolysis	Intrinsic/Extrinsic	Hb concentration	MCV	RDW	Reticulocytosis	Haptoglobin levels	Hepcidin	Serum iron	Serum Tfr level	IBC	Ferritin	Transferrin saturation	Specific finding on blood smear

Differentaition from other causes of Thrombocytopenia

Category	Condition		Etiology	Mechanism			Inherited	Acquried	Clinical manifestations									Para−clinical findings								Gold standard	Associated findings
									Demography	History	Symptoms			Signs				Para−clinical findings
											Symptoms			Signs				Lab Findings
											Fever	Rash	Bleeding	BP	Splenomegaly	Jaundice	Other	CBC			PBS	Bone marrow exam	PT	PTT	UA
				Decreased platelet production	Platelet destruction in blood	Platelet destruction in spleen					Fever	Rash	Bleeding	BP	Splenomegaly	Jaundice	Other	Plt	HB	WBC	PBS	Bone marrow exam	PT	PTT	UA
Hematology	Bone marrow disorders	Myelodysplastic syndromes^[12]	Unknown Mutation	+	−	−	±	+	Elderly	Exposure to Chemotherapy Radiation therapy Tobacco smoke	+	Petechiae, purpura, diffuse erythematous rash	+	Nl	+	+	Shortness of breath Fatigue Pallor	↓	↓	↓	Ovalomacrocytosis Basophilic stippling Howell-Jolly body Dysplastic neutrophils	Impaired myeloid maturation Dyserythropoiesis Dysgranulopoiesis Dysmegakaryocytopoiesis Hypercellular bone marrow Fibrosis	Nl	Nl	Nl	Bone marrow examination + clinical manifestation	Might transformed to acute leukemia
		Aplastic anemia^[13]	Unknown secondary to radiation, drugs and chemicals, pregnancy, PNH and viral or autoimmune causes	+	−	−	±	±	Biphasic (the young and the elderly)	Exposure to chemicals Radiation History of prior drug use Viral infection Positive family history of aplastic anemia	−	−	+	Nl	−	−	Shortness of breath Fatigue Pallor	↓	↓	↓	Large RBCs Low platelets and granulocytes	Hypocellular bone marrow replacement of bone marrow by fat	↑	↑	Nl	Bone marrow examination + laboratory findings	Fanconi Anemia Dyskeratosis congenita Schwachman-Diamond syndrome Preleukemia
		Acute leukemia^[14]^[15]	Immune mediated Chromosomal abnormalities	+	+	−	±	±	AML in adults	Exposure to chemicals Radiation Pre-existent blood disorders	±	Petechiae	+	Nl	±	−	Weakness	↓	↓	↓	Pancytopenia	Blast cells	↑	↑	Hemoglobinuria	Bone marrow examination	Tumor lysis syndrome Infection CNS involvement DIC
		Paroxysmal nocturnal hemoglobinuria (PNH)^[16]	Deficiency of complement regulatory proteins Mutations	+	+	−	−	+	Any age (usually younger adults)	Sudden nocturnal hemoglobinuria with partial clearing during the day	−	−	−	Nl	−	−	Thrombosis Smooth muscle dystonia	↓/Nl	↓	↓/Nl	Pancytopenia	Cellular marrow Erythroid hyperplasia dyserythropoiesis Hypocellular marrow in certain stages of the disease	Nl	Nl	Hemoglobinuria	Flow cytometry	Chronic renal failure Pulmonary hypertension Aplastic anemia
	Condition		Etiology	Decreased platelet production	Platelet destruction in blood	Platelet destruction in spleen	Inherited	Acquried	Demography	History	Fever	Rash	Bleeding	BP	Splenomegaly	Jaundice	Other signs	Plt	HB	WBC	PBS	Bone marrow exam	PT	PTT	UA	Gold standard	Associated findings
	Thrombotic microangiopathy (TMA)	Thrombotic thrombocytopenic purpura (TTP)^[17]	Deficiency of, or antibodies to, the metalloprotease ADAMTS13	−	+	−	±	+	Any age	Neurologic manifestations Fatigue due to anemia	+	Petechiae	Not common	Nl or ↑	−	+	Neurologic findings Signs of renal impairment	↓	↓	Nl or ↑	Fragmented RBCs	NA	Nl	Nl	Hemoglobinuria	Laboratory findings	Hemolysis Microvascular thrombosis
		Hemolytic uremic syndrome (HUS)^[18]	Escherichia coli O157:H7 Genetic defects	−	+	−	±	+	Children	Exposure to contaminated water or milk Consuming undercooked ground beef	+	Petechiae	−	↓	−	+	Abdominal tenderness Diarrhea	↓	↓	Nl or ↑	Fragmented RBCs	NA	Nl	Nl	Hemoglobinuria	Laboratory findings	Acute renal failure Hemolysis Microvascular thrombosis
		DIC^[19]^[20]	Overstimulation of the coagulation system	+	+	−	−	+	Any age	History of trauma, sepsis, malignancy, vasculitis or exogenous toxins	+	+	+	↓	−	+	Neurologic findings Signs of renal impairment	↓	↓↓	↑	Schistocytes Helmet cells	Low platelets Low RBCs	↑↑	↑	Hemoglobinuria	Clinical manifestation + laboratory findings	Hemolysis Microangiopathy Multi-organ dysfunction
	Nutrient deficiencies	Folate, vitamin B12, copper deficiencies^[21]^[22]	Decreased platelet production	+	−	−	−	+	Any age	Malnutrition Alcohol use	−	−	−	Nl	−	−	Fatigue Weakness	↓	↓	Nl	Low platelets Low RBCs	Low platelets Low RBCs	Nl	Nl	Nl	Laboratory findings	Megaloblastic anemia
	Condition		Etiology	Decreased platelet production	Platelet destruction in blood	Platelet destruction in spleen	Inherited	Acquried	Demography	History	Fever	Rash	Bleeding	BP	Splenomegaly	Jaundice	Other signs	Plt	HB	WBC	PBS	Bone marrow exam	PT	PTT	UA	Gold standard	Associated findings
	Congenital platelet disorders^[23]^[24]^[25]	MYH9-related disorders^[26]	Cytoskeletal defects in megakaryocytes Mutation	+	−	−	+	−	Any age, very rare	Positive family history	−	Petechiae	+	Nl	−	−	Hearing loss Renal impairment Cataract	↓	↓	Nl	Large platelets Döhle body-like inclusions in peripheral blood neutrophils	NA	Nl	Nl	Nl	Genetic study	Autosomal dominant
		Bernard-Soulier syndrome^[27]	Absence of Gp Ib-IX-V	+	−	−	+	−	Children, rare	Positive family history	−	−	+	Nl	−	−	−	↓	Nl	Nl	Large platelets	Large platelets	Nl	Nl	Nl	Flow cytometry	Autosomal recessive Increased bleeding time
		Gray platelet syndrome^[28]	Reduction or absence of alpha-granules in blood platelets	+	−	−	+	−	Rare	Positive family history	−	Petechiae	+ Mucocutaneous	Nl	+	−	Epistaxis	↓	Nl	Nl	Large platelets and lack of granulation	Myelofibrosis	Nl	Nl	Nl	Genetic study	Autosomal recessive
		Wiskott-Aldrich syndrome^[29]	Mutation in GATA-1	+	−	−	+	−	Rare	Positive family history	−	Eczema	+	Nl	−	−	Bloody diarrhea	↓	Nl	Nl	Small but low platelets	Small but low platelets	Nl	Nl	Nl	Genetic study	Recurrent infections autoimmune disorders Malignancy
		Thrombocytopenia with absent radius (TAR) syndrome^[30]	1q21.1 deletion and bone marrow failure	+	−	−	+	−	Children	Positive family history	−	+	+	Nl	−	−	Bilateral radial aplasia	↓	Nl	Nl or ↑	Normal size platelets	Normal or hypercellular bone marrow Decreased, absent, or immature megakaryocytes Small, basophilic, vacuolated megakaryocytes Erythroid hyperplasia	Nl	Nl	Nl	Evidence of absent radius + Laboratory findings	Cow's milk allergy Various other anomalies
		Fechtner syndrome^[31]	Mutation of chromosome 22q11-13	+	−	−	+	−	Children	Positive family history	−	Ecchymoses and petechia	+ Mucocutaneous	Nl	−	−	Hearing loss Eye abnormalities	↓	Nl	Nl or ↑	Large platelets Granulocytic inclusions	NA	Nl	Nl	Microscopic hematuria Pyuria Red cell casts Cylindrical casts Proteinuria	Clinical manifestation + genetic study	Autosomal dominant variant of Alport syndrome Renal failure Hypoalbuminemia
		Von Willebrand disease^[32]	VWF deficiency/dysfunction	+	−	−	+	Rarely	More common with O blood type	Positive family history	−	−	+	−	−	−	−	Nl/ ↓	Nl/↓	Nl	Large platelets	NA	Nl	Nl or ↑	Hematuria	Laboratory findings	Lifelong bleeding disorder
Category	Condition		Etiology	Decreased platelet production	Platelet destruction in blood	Platelet destruction in spleen	Inherited	Acquried	Demography	History	Fever	Rash	Bleeding	BP	Splenomegaly	Jaundice	Other signs	Plt	HB	WBC	PBS	Bone marrow exam	PT	PTT	UA	Gold standard	Associated findings
Rheumatologic/autoimmune disorders	ITP^[33]		Immune-mediated platelet destruction Inhibition of platelet release from the megakaryocyte	+	+	−	−	+	Any age	−	−	Ecchymoses and petechia	+ Mucocutaneous	Nl	−	−	−	↓↓↓	Nl	Nl	Nl	Large platelets, otherwise normal	Nl	Nl	Nl	Diagnosis of exclusion	Spontaneous remission
	Systemic lupus erythematosus^[34]		Immune-mediated platelet destruction	−	+	−	−	+	Young women, more prevalent in Africans and Asians	Medication use History of weight changes Other rheumatologic and autoimmune diseases Family history of rheumatologic diseases	+	Malar rash, generalized maculopapular rash, discoid rash	+ Hemoptysis	Nl or ↑	+	+	Mucosal ulcers Lymphadenopathy Crackles Chest tenderness Murmur Hepatomegaly Cognitive impairment	↓	↓	↓	Pancytopenia	Pancytopenia	↑	↑	Hematuria Pyuria Proteinuria Cellular casts	Clinical manifestation + serology	TTP Multiorgan dysfunction Infections Atherosclerosis Malignancies Poor prognosis with lupus nephritis
	Antiphospholipid syndrome^[35]		Autoantibody-mediated syndrome	−	+	−	+	+	Middle aged women, more in African American and Hispanic population	Abortion Other rheumatologic and autoimmune diseases Family history of rheumatologic diseases	−	−	−	Nl	−	−	DVT	↓	Nl	↓	Reduced platelets and WBC	Reduced platelets and WBC	Nl	↑	Hematuria	Clinical manifestation + repeated positive tests of aPL	Recurrent thrombosis Stroke
	Felty's syndrome^[36]		Autoantibody-mediated syndrome Splenomegaly	−	+	+	±	+	Rare, young women	Arthritis Family history of RA	−	Necrotizing skin lesions Rheumatoid nodule	−	Nl	+	−	Lymphadenopathy	↓	Nl	↓	Reduced platelets and WBC	Reduced platelets and WBC	Nl	Nl	Nl	Clinical manifestation	Rheumatoid arthritis Positive RF and anti-citrullinated peptide antibodies Episcleritis Pleuropericarditis
Category	Condition		Etiology	Decreased platelet production	Platelet destruction in blood	Platelet destruction in spleen	Inherited	Acquried	Demography	History	Fever	Rash	Bleeding	BP	Splenomegaly	Jaundice	Other signs	Plt	HB	WBC	PBS	Bone marrow exam	PT	PTT	UA	Gold standard	Associated findings
Infection-induced	Bacterial infections	Sepsis^[37]	Direct bone marrow suppression	+	+	−	−	+	Any	Bacterial infection	+	Petechiae Purpura Erythema Ulceration	±	Nl to ↓	−	±	Malaise Lymphadenopathy	↓/↑	Nl	↑↑	Reduced platelets	NA	↑	↑	+ Depends on the etiology	Clinical manifestation + culture	Associated with ↑ mortality
		Helicobacter pylori^[38]	Immune thrombocytopenia	−	+	−	−	+	Any	−	−	−	−	Nl	−	−	Epigastric tenderness Heartburn	↓	Nl	Nl	Reduced platelets	NA	Nl	Nl	Nl	Clinical manifestation + culture	GERD
		Tick-borne infection^[39]	Immune thrombocytopenia	−	+	−	−	+	Endemic area like China, Japan, and Korea	Being bitten by a tick	+	Petechiae Purpura Erythema Ulceration	±	Nl to ↓	±	±	Encephalitis Hemorrhagic fever	↓	Nl	↓	Reduced platelets	NA	Nl	Nl	Proteinuria	PCR	Elevated ALT and AST Multiple organ failure Lymphadenopathy
	Viral infections	HIV^[40]	Immune thrombocytopenia	+	+	+	−	+	Any	High risk behaviors Close contact	+	Skin lesions	±	Nl to ↓	±	±	Lymphadenopathy Muscle weakness Joint swelling Focal neurological deficits	↓	↓	↓	Pancytopenia	Pancytopenia	↑	↑	Proteinuria	Isolation of HIV	Malignancy Severe immunodeficiency
	Viral infections	Other viruses such as rubella, mumps, varicella, parvovirus, hepatitis C, & Epstein-Barr virus^[41]	Immune thrombocytopenia	+	−	−	−	+	Any	High risk behaviors Close contact	+	Petechiae Purpura	−	Nl	±	±	Lymphadenopathy Muscle weakness Joint swelling Focal neurological deficits Depends on etiology	↓	↓	↓	Pancytopenia	Pancytopenia	Nl	Nl	Hematuria	Clinical manifestation + lab tests	Depends on etiology Encephalomyelitis
	Parasitic infections	Malaria^[42]	Unknown Immune thrombocytopenia	+	−	−	−	+	Endemic area	Being bitten by a mosquito	+	−	±	Nl to ↓	±	±	Headache Weakness Night sweats Joint pain Muscle pain	↓	↓	↓	Pancytopenia	Pancytopenia	Nl	Nl	Hematuria	Clinical manifestation + microscopic examination of blood smear	Life-threatening disease Multiple organ failure
	Parasitic infections	Babesiosis^[43]	Unknown Immune thrombocytopenia	+	−	−	−	+	Rare	Being bitten by a tick Immunodeficiency	+	−	±	Nl to ↓	±	±	Fatigue Chills Sweats Headache	↓	↓	↓	Pancytopenia	Pancytopenia	Nl	Nl	Hematuria	Clinical manifestation + microscopic examination of blood smear	Severe hemolytic anemia DIC Multiple organ failure
Category	Condition		Etiology	Decreased platelet production	Platelet destruction in blood	Platelet destruction in spleen	Inherited	Acquried	Demography	History	Fever	Rash	Bleeding	BP	Splenomegaly	Jaundice	Other signs	Plt	HB	WBC	PBS	Bone marrow exam	PT	PTT	UA	Gold standard	Associated findings
Medication/toxicity	Antibiotics/ Antiepileptic^[44]	Quinine Sulfonamides Carbamazepine Phenytoin	Occurrence of drug-dependent, platelet-reactive antibodies	+	+	−	−	+	Any	Drug ingestion or injection	−	Ecchymoses Petechia	−	Nl	−	−	−	↓↓	↓	Nl	Reduced platelets	NA	Nl	Nl	Nl	Clinical manifestation + exclusion of the other causes	NA
	Heparin-induced thrombocytopenia^[45]		Anti-heparin/PF4 antibody	−	+	−	−	+	Any	Heparin injection	−	Necrotic skin lesions	−	Nl	−	−	−	↓	Nl	Nl	Reduced platelets	NA	Nl	Nl	Nl	ELISA	Early or delayed-onset Thrombosis
	Cytotoxic chemotherapy^[46]		Bone marrow suppression	+	−	−	−	+	Patients with malignancy	Drug ingestion or injection Cancer	−	Ecchymoses Petechia	−	Nl	−	−	−	↓	↓	↓	Reduced platelets	Megakaryocytic hypoplasia or aplasia	↑	↑	Hematuria	Clinical manifestation + exclusion of the other causes	Thrombosis
	Radiation therapy^[47]		Predictable, dose-dependent myelosuppression	+	−	−	−	+	Patients with malignancy	Radiation Cancer	−	Purpura Petechiae	+	Nl	−	−	−	↓	↓	↓	Reduced platelets	Megakaryocytic hypoplasia or aplasia	↑	↑	Hematuria	Clinical manifestation + exclusion of the other causes	Thrombosis
GI	Chronic liver disease^[48]		Bone marrow suppression	+	−	−	−	+	Any	Cirrhosis Alcohol use	−	Purpura Petechiae	+	↓	+	+	−	↓	↓	Nl	Reduced platelets	NA	↑	↑	Nl	Biopsy	Portal vein thrombosis Hepatorenal syndrome Variceal hemorrhage Hepatic hydrothorax Spontaneous bacterial peritonitis
GI	Portal hypertension^[49]		Bone marrow suppression	+	−	−	−	+	Any	Cirrhosis Alcohol use	−	Purpura Petechiae	+	↓	+	+	−	↓	↓	Nl	Reduced platelets	NA	↑	↑	Nl	Clinical manifestation	Portal vein thrombosis Ascites
Category	Condition		Etiology	Decreased platelet production	Platelet destruction in blood	Platelet destruction in spleen	Inherited	Acquried	Demography	History	Fever	Rash	Bleeding	BP	Splenomegaly	Jaundice	Other signs	Plt	HB	WBC	PBS	Bone marrow exam	PT	PTT	UA	Gold standard	Associated findings
Vascular	Giant capillary hemangioma (Kasabach-Merritt syndrome)^[50]^[51]		Platelet destruction	−	+	−	+	−	Infants	Rare but serious infantile coagulopathy	−	Multiple purple hemangioma	Intralesional bleeding	Nl	−	−	Visceral hemangiomas	↓↓	↓↓	Nl	Normocytic normochromic erythrocytes and markedly reduced platelets	Normal erythropoiesis, myelopoiesis, and megakaryocytic hyperplasia	↑	↑	Hematuria	Biopsy	Kaposiform hemangioendothelioma Tufted angioma
Vascular	Cardiopulmonary bypass^[52]		Platelet destruction	−	+	−	−	+	Elderly	Coronary artery disease	−	Purpura Petechiae	+	Nl or ↑	−	−	−	↓	↓	Nl	Normocytic normochromic erythrocytes and markedly reduced platelets	NA	↑	↑	Hematuria	Clinical manifestation	Coagulopathy Hypofibrinogenemia
Other	Alcohol^[53]		Platelet production suppression	+	−	+	−	+	Any	History of alcohol use	−	−	−	Nl	+	+	Hepatomegaly	↓	↓	↓	Cytopenia, macrocytosis	Cytopenia, macrocytosis	↑	↑	Nl	Clinical manifestation	Chronic liver disease
	Post-transfusion purpura^[54]^[55]		Platelet destruction by anti-platelet antibodies	−	+	−	−	+	Women	History of blood transfusion or pregnancy	−	Purpura Petechiae	+	↓	−	−	−	↓↓↓	↓	Nl	Nl	NA	Nl	Nl	Nl	Positive circulating alloantibody to a common platelet antigen	Severe but rare reaction
	Gestational thrombocytopenia^[56]		Might be physiologic adaptation of pregnancy	−	−	−	−	+	Pregnant women	Positive history of mild thrombocytopenia	−	−	−	Nl	−	−	−	↓	Nl	Nl	Nl	NA	Nl	Nl	Nl	Diagnosis of exclusion	Self-limited condition
	HELLP syndrome^[57]^[58]		Unknown	−	+	−	−	+	Pregnant > 25 years	History of preeclampsia	−	−	+	↑	−	+	Abdominal tenderness Ascites	↓	↓	Nl	Schistocytes	NA	Nl	Nl	Proteinuria	Lab abnormalities	Elevated liver enzymes and bilirubin Multiorgan dysfunction
	Idiopathic cyclic thrombocytopenia^[59]		Unknown Might be autoimmune platelet destruction	+	+	−	−	+	Females with the median age of onset 35 years	Misdiagnosed as ITP with uniformly poor responses	−	Purpura Petechiae	Minor mucocutaneous bleeding	Nl	−	−	−	↓	Nl	Nl	Reduced platelets and megakaryocytes	Megakaryocytic hypoplasia or aplasia	Nl	Nl	Nl	Diagnosis of exclusion	Rebound thrombocytosis Myeloproliferative diseases Myelodysplastic syndrome
	Pseudothrombocytopenia^[60]		Platelet clumping due to EDTA	−	−	−	−	+	Rare	Collected sample in EDTA anticoagulant	−	−	−	Nl	−	−	−	↓	Nl	Nl	Low platelet count and platelet clumps	Low platelet count and platelet clumps	Nl	Nl	Nl	Repeat collecting sample in a heparin tube	Nl
Category	Condition		Etiology	Decreased platelet production	Platelet destruction in blood	Platelet destruction in spleen	Inherited	Acquried	Demography	History	Fever	Rash	Bleeding	BP	Splenomegaly	Jaundice	Other signs	Plt	HB	WBC	PBS	Bone marrow exam	PT	PTT	UA	Gold standard	Associated findings

References

↑ Differential diagnosis of myelodysplastic syndromes. Librepathology (2015). http://librepathology.org/wiki/index.php/Myelodysplastic_syndromes. Accessed on December 9, 2015
↑ Merrill, Andrea L.; Smith, Hedy (2011). "Myelodysplastic Syndrome and Autoimmunity: A Case Report of an Unusual Presentation of Myelodysplastic Syndrome". Case Reports in Hematology. 2011: 1–4. doi:10.1155/2011/560106. ISSN 2090-6560.
↑ DeZern, A. E.; Sekeres, M. A. (2014). "The Challenging World of Cytopenias: Distinguishing Myelodysplastic Syndromes From Other Disorders of Marrow Failure". The Oncologist. 19 (7): 735–745. doi:10.1634/theoncologist.2014-0056. ISSN 1083-7159.
↑ Weinzierl, E. P.; Arber, D. A. (2012). "The Differential Diagnosis and Bone Marrow Evaluation of New-Onset Pancytopenia". American Journal of Clinical Pathology. 139 (1): 9–29. doi:10.1309/AJCP50AEEYGREWUZ. ISSN 0002-9173.
↑ Koike H, Takahashi M, Ohyama K, Hashimoto R, Kawagashira Y, Iijima M, Katsuno M, Doi H, Tanaka F, Sobue G (March 2015). "Clinicopathologic features of folate-deficiency neuropathy". Neurology. 84 (10): 1026–33. doi:10.1212/WNL.0000000000001343. PMID 25663227.
↑ Hunt A, Harrington D, Robinson S (September 2014). "Vitamin B12 deficiency". BMJ. 349: g5226. PMID 25189324.
↑ Grohmann K, Lauffer H, Lauenstein P, Hoffmann GF, Seidlitz G (April 2015). "Hereditary orotic aciduria with epilepsy and without megaloblastic anemia". Neuropediatrics. 46 (2): 123–5. doi:10.1055/s-0035-1547341. PMID 25757096.
↑ Alter BP (2014). "Fanconi anemia and the development of leukemia". Best Pract Res Clin Haematol. 27 (3–4): 214–21. doi:10.1016/j.beha.2014.10.002. PMC 4254647. PMID 25455269.
↑ Vlachos A, Blanc L, Lipton JM (June 2014). "Diamond Blackfan anemia: a model for the translational approach to understanding human disease". Expert Rev Hematol. 7 (3): 359–72. doi:10.1586/17474086.2014.897923. PMID 24665981.
↑ Marks PW (July 2013). "Hematologic manifestations of liver disease". Semin. Hematol. 50 (3): 216–21. doi:10.1053/j.seminhematol.2013.06.003. PMID 23953338.
↑ Yokoyama A, Yokoyama T, Brooks PJ, Mizukami T, Matsui T, Kimura M, Matsushita S, Higuchi S, Maruyama K (May 2014). "Macrocytosis, macrocytic anemia, and genetic polymorphisms of alcohol dehydrogenase-1B and aldehyde dehydrogenase-2 in Japanese alcoholic men". Alcohol. Clin. Exp. Res. 38 (5): 1237–46. doi:10.1111/acer.12372. PMID 24588059.
↑ Natelson, Ethan A.; Pyatt, David (2013). "Acquired Myelodysplasia or Myelodysplastic Syndrome: Clearing the Fog". Advances in Hematology. 2013: 1–11. doi:10.1155/2013/309637. ISSN 1687-9104.
↑ Townsley, Danielle M.; Desmond, Ronan; Dunbar, Cynthia E.; Young, Neal S. (2013). "Pathophysiology and management of thrombocytopenia in bone marrow failure: possible clinical applications of TPO receptor agonists in aplastic anemia and myelodysplastic syndromes". International Journal of Hematology. 98 (1): 48–55. doi:10.1007/s12185-013-1352-6. ISSN 0925-5710.
↑ Oshima, Yasuo; Yuji, Koichiro; Tanimoto, Tetsuya; Hinomura, Yasushi; Tojo, Arinobu (2013). "Association between Acute Myelogenous Leukemia and Thrombopoietin Receptor Agonists in Patients with Immune Thrombocytopenia". Internal Medicine. 52 (19): 2193–2201. doi:10.2169/internalmedicine.52.0324. ISSN 0918-2918.
↑ Oshima Y, Yuji K, Tanimoto T, Hinomura Y, Tojo A (2013). "Association between acute myelogenous leukemia and thrombopoietin receptor agonists in patients with immune thrombocytopenia". Intern. Med. 52 (19): 2193–201. PMID 24088751.
↑ Brodsky RA (2014). "Paroxysmal nocturnal hemoglobinuria". Blood. 124 (18): 2804–11. doi:10.1182/blood-2014-02-522128. PMC 4215311. PMID 25237200.
↑ Noris M, Mescia F, Remuzzi G (November 2012). "STEC-HUS, atypical HUS and TTP are all diseases of complement activation". Nat Rev Nephrol. 8 (11): 622–33. doi:10.1038/nrneph.2012.195. PMID 22986360.
↑ Conway EM (October 2015). "HUS and the case for complement". Blood. 126 (18): 2085–90. doi:10.1182/blood-2015-03-569277. PMID 26396094.
↑ Schwameis M, Schörgenhofer C, Assinger A, Steiner MM, Jilma B (April 2015). "VWF excess and ADAMTS13 deficiency: a unifying pathomechanism linking inflammation to thrombosis in DIC, malaria, and TTP". Thromb. Haemost. 113 (4): 708–18. doi:10.1160/TH14-09-0731. PMC 4745134. PMID 25503977.
↑ Kitchens CS (2009). "Thrombocytopenia and thrombosis in disseminated intravascular coagulation (DIC)". Hematology Am Soc Hematol Educ Program: 240–6. doi:10.1182/asheducation-2009.1.240. PMID 20008204.
↑ Clarke, V.; Weston-Smith, S. (2010). "Severe folate-deficiency pancytopenia". Case Reports. 2010 (oct18 2): bcr0320102851–bcr0320102851. doi:10.1136/bcr.03.2010.2851. ISSN 1757-790X.
↑ Blackmer AB, Bailey E (February 2013). "Management of copper deficiency in cholestatic infants: review of the literature and a case series". Nutr Clin Pract. 28 (1): 75–86. doi:10.1177/0884533612461531. PMID 23069991.
↑ Nurden AT, Freson K, Seligsohn U (2012). "Inherited platelet disorders". Haemophilia. 18 Suppl 4: 154–60. doi:10.1111/j.1365-2516.2012.02856.x. PMID 22726100.
↑ Balduini, Carlo L.; Savoia, Anna (2012). "Genetics of familial forms of thrombocytopenia". Human Genetics. 131 (12): 1821–1832. doi:10.1007/s00439-012-1215-x. ISSN 0340-6717.
↑ D'Andrea G, Chetta M, Margaglione M (2009). "Inherited platelet disorders: thrombocytopenias and thrombocytopathies". Blood Transfus. 7 (4): 278–92. doi:10.2450/2009.0078-08. PMC 2782805. PMID 20011639.
↑ Zhang S, Zhou X, Liu S, Bai T, Zhang Y, Wang J, Wang S, Zhang X, Wang B (2014). "MYH9-related disease: description of a large Chinese pedigree and a survey of reported mutations". Acta Haematol. 132 (2): 193–8. doi:10.1159/000356681. PMID 24643058.
↑ Berndt MC, Andrews RK (March 2011). "Bernard-Soulier syndrome". Haematologica. 96 (3): 355–9. doi:10.3324/haematol.2010.039883. PMC 3046265. PMID 21357716.
↑ Michelson AD (January 2013). "Gray platelet syndrome". Blood. 121 (2): 250. PMID 23427340.
↑ Candotti F (January 2018). "Clinical Manifestations and Pathophysiological Mechanisms of the Wiskott-Aldrich Syndrome". J. Clin. Immunol. 38 (1): 13–27. doi:10.1007/s10875-017-0453-z. PMID 29086100.
↑ Al-Qattan MM (November 2016). "The Pathogenesis of Radial Ray Deficiency in Thrombocytopenia-Absent Radius (TAR) Syndrome". J Coll Physicians Surg Pak. 26 (11): 912–916. doi:2476 Check |doi= value (help). PMID 27981927.
↑ Toren A, Amariglio N, Rozenfeld-Granot G, Simon AJ, Brok-Simoni F, Pras E, Rechavi G (December 1999). "Genetic linkage of autosomal-dominant Alport syndrome with leukocyte inclusions and macrothrombocytopenia (Fechtner syndrome) to chromosome 22q11-13". Am. J. Hum. Genet. 65 (6): 1711–7. doi:10.1086/302654. PMC 1288382. PMID 10577925.
↑ Langer F, Obser T, Oyen F, Spath B, Holstein K, Greinacher A, White JG, Budde U, Bokemeyer C, Schneppenheim R (April 2014). "Characterisation of the p.A1461D mutation causing von Willebrand disease type 2B with severe thrombocytopenia, circulating giant platelets, and defective α-granule secretion". Thromb. Haemost. 111 (4): 777–9. doi:10.1160/TH13-06-0462. PMID 24337418.
↑ Zufferey, Anne; Kapur, Rick; Semple, John (2017). "Pathogenesis and Therapeutic Mechanisms in Immune Thrombocytopenia (ITP)". Journal of Clinical Medicine. 6 (2): 16. doi:10.3390/jcm6020016. ISSN 2077-0383.
↑ Abu-Hishmeh M, Sattar A, Zarlasht F, Ramadan M, Abdel-Rahman A, Hinson S, Hwang C (October 2016). "Systemic Lupus Erythematosus Presenting as Refractory Thrombotic Thrombocytopenic Purpura: A Diagnostic and Management Challenge. A Case Report and Concise Review of the Literature". Am J Case Rep. 17: 782–787. PMC 5083062. PMID 27777394.
↑ Artim-Esen, Bahar; Diz-Küçükkaya, Reyhan; İnanç, Murat (2015). "The Significance and Management of Thrombocytopenia in Antiphospholipid Syndrome". Current Rheumatology Reports. 17 (3). doi:10.1007/s11926-014-0494-8. ISSN 1523-3774.
↑ Chavalitdhamrong, Disaya; Molovic-Kokovic, Ana; Iliev, Andrey (2009). "Felty's Syndrome as an initial presentation of Rheumatoid Arthritis: a case report". Cases Journal. 2 (1): 206. doi:10.1186/1757-1626-2-206. ISSN 1757-1626.
↑ Wu, Qin; Ren, Jianan; Wu, Xiuwen; Wang, Gefei; Gu, Guosheng; Liu, Song; Wu, Yin; Hu, Dong; Zhao, Yunzhao; Li, Jieshou (2014). "Recombinant human thrombopoietin improves platelet counts and reduces platelet transfusion possibility among patients with severe sepsis and thrombocytopenia: A prospective study". Journal of Critical Care. 29 (3): 362–366. doi:10.1016/j.jcrc.2013.11.023. ISSN 0883-9441.
↑ Kuwana M (January 2014). "Helicobacter pylori-associated immune thrombocytopenia: clinical features and pathogenic mechanisms". World J. Gastroenterol. 20 (3): 714–23. doi:10.3748/wjg.v20.i3.714. PMC 3921481. PMID 24574745.
↑ Liu Q, He B, Huang SY, Wei F, Zhu XQ (August 2014). "Severe fever with thrombocytopenia syndrome, an emerging tick-borne zoonosis". Lancet Infect Dis. 14 (8): 763–772. doi:10.1016/S1473-3099(14)70718-2. PMID 24837566.
↑ Borges ÁH, Lundgren JD, Mocroft A (July 2015). "Thrombocytopenia and cancer risk during HIV infection". AIDS. 29 (11): 1425–7. doi:10.1097/QAD.0000000000000744. PMID 26098601.
↑ Saeed M, Dabbagh O, Al-Muhaizae M, Dhalaan H, Chedrawi A (November 2014). "Acute disseminated encephalomyelitis and thrombocytopenia following Epstein-Barr virus infection". J Coll Physicians Surg Pak. 24 Suppl 3: S216–8. doi:11.2014/JCPSP.S216S218 Check |doi= value (help). PMID 25518779.
↑ Rodriguez-Morales AJ, Giselle-Badillo A, Manrique-Castaño S, Yepes MC (2014). "Anemia and thrombocytopenia in Plasmodium vivax malaria is not unusual in patients from endemic and non-endemic settings". Travel Med Infect Dis. 12 (5): 549–50. doi:10.1016/j.tmaid.2014.07.006. PMID 25131143.
↑ Nackos E, DeSancho M (March 2014). "Anemia and thrombocytopenia: diagnosis from the blood smear". Blood. 123 (12): 1783. PMID 24783256.
↑ Visentin GP, Liu CY (August 2007). "Drug-induced thrombocytopenia". Hematol. Oncol. Clin. North Am. 21 (4): 685–96, vi. doi:10.1016/j.hoc.2007.06.005. PMC 1993236. PMID 17666285.
↑ Lovecchio, F. (2014). "Heparin-induced thrombocytopenia". Clinical Toxicology. 52 (6): 579–583. doi:10.3109/15563650.2014.917181. ISSN 1556-3650.
↑ Parameswaran, R.; Lunning, M.; Mantha, S.; Devlin, S.; Hamilton, A.; Schwartz, G.; Soff, G. (2014). "Romiplostim for management of chemotherapy-induced thrombocytopenia". Supportive Care in Cancer. 22 (5): 1217–1222. doi:10.1007/s00520-013-2074-2. ISSN 0941-4355.
↑ Bercovitz RS, Josephson CD (2012). "Thrombocytopenia and bleeding in pediatric oncology patients". Hematology Am Soc Hematol Educ Program. 2012: 499–505. doi:10.1182/asheducation-2012.1.499. PMID 23233625.
↑ Loffredo, Lorenzo; Violi, Francesco (2018). "Thrombopoietin receptor agonists and risk of portal vein thrombosis in patients with liver disease and thrombocytopenia: A meta-analysis". Digestive and Liver Disease. doi:10.1016/j.dld.2018.06.005. ISSN 1590-8658.
↑ Jia YP, Lu Q, Gong S, Ma BY, Wen XR, Peng YL, Lin L, Chen HY, Qiu L, Luo Y (September 2007). "Postoperative complications in patients with portal vein thrombosis after liver transplantation: evaluation with Doppler ultrasonography". World J. Gastroenterol. 13 (34): 4636–40. PMC 4611842. PMID 17729421.
↑ Lewis D, Vaidya R. Kasabach Merritt Syndrome. [Updated 2018 Jul 27]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2018 Jan-. Available from: https://www-ncbi-nlm-nih-gov.ezp-prod1.hul.harvard.edu/books/NBK519053/
↑ Vinod, Kolar Vishwanath; Johny, Joseph; Vadivelan, Mehalingam; Hamide, Abdoul (2017). "Kasabach-Merritt Syndrome in an adult". Turkish Journal of Hematology. doi:10.4274/tjh.2017.0429. ISSN 1300-7777.
↑ Ji, Sung-Mi; Kim, Sung-Hoon; Nam, Jae-Sik; Yun, Hye-Joo; Choi, Jeong-Hyun; Lee, Eun-Ho; Choi, In-Cheol (2015). "Predictive value of rotational thromboelastometry during cardiopulmonary bypass for thrombocytopenia and hypofibrinogenemia after weaning of cardiopulmonary bypass". Korean Journal of Anesthesiology. 68 (3): 241. doi:10.4097/kjae.2015.68.3.241. ISSN 2005-6419.
↑ Latvala J, Parkkila S, Niemelä O (April 2004). "Excess alcohol consumption is common in patients with cytopenia: studies in blood and bone marrow cells". Alcohol. Clin. Exp. Res. 28 (4): 619–24. PMID 15100613.
↑ McCrae, Keith R.; Herman, Jay H. (1996). "Posttransfusion purpura: Two unusual cases and a literature review". American Journal of Hematology. 52 (3): 205–211. doi:10.1002/(SICI)1096-8652(199607)52:3<205::AID-AJH13>3.0.CO;2-E. ISSN 0361-8609.
↑ Pavenski, Katerina; Webert, Kathryn E.; Goldman, Mindy (2008). "Consequences of transfusion of platelet antibody: a case report and literature review". Transfusion. 48 (9): 1981–1989. doi:10.1111/j.1537-2995.2008.01796.x. ISSN 0041-1132.
↑ Reese, Jessica A.; Peck, Jennifer D.; Deschamps, David R.; McIntosh, Jennifer J.; Knudtson, Eric J.; Terrell, Deirdra R.; Vesely, Sara K.; George, James N. (2018). "Platelet Counts during Pregnancy". New England Journal of Medicine. 379 (1): 32–43. doi:10.1056/NEJMoa1802897. ISSN 0028-4793.
↑ Barnhart, Lynette (2015). "HELLP Syndrome and the Effects on the Neonate". Neonatal Network. 34 (5): 269–273. doi:10.1891/0730-0832.34.5.269. ISSN 0730-0832.
↑ Haram, Kjell; Svendsen, Einar; Abildgaard, Ulrich (2009). "The HELLP syndrome: Clinical issues and management. A Review". BMC Pregnancy and Childbirth. 9 (1). doi:10.1186/1471-2393-9-8. ISSN 1471-2393.
↑ Go, Ronald S. (2005). "Idiopathic cyclic thrombocytopenia". Blood Reviews. 19 (1): 53–59. doi:10.1016/j.blre.2004.05.001. ISSN 0268-960X.
↑ Tan, Geok Chin; Stalling, Melissa; Dennis, Gretchen; Nunez, Maria; Kahwash, Samir B. (2016). "Pseudothrombocytopenia due to Platelet Clumping: A Case Report and Brief Review of the Literature". Case Reports in Hematology. 2016: 1–4. doi:10.1155/2016/3036476. ISSN 2090-6560.

Template:WikiDoc Sources

[Librepathology3-1] Differential diagnosis of myelodysplastic syndromes. Librepathology (2015). http://librepathology.org/wiki/index.php/Myelodysplastic_syndromes. Accessed on December 9, 2015

[MerrillSmith2011-2] Merrill, Andrea L.; Smith, Hedy (2011). "Myelodysplastic Syndrome and Autoimmunity: A Case Report of an Unusual Presentation of Myelodysplastic Syndrome". Case Reports in Hematology. 2011: 1–4. doi:10.1155/2011/560106. ISSN 2090-6560.

[DeZernSekeres2014-3] DeZern, A. E.; Sekeres, M. A. (2014). "The Challenging World of Cytopenias: Distinguishing Myelodysplastic Syndromes From Other Disorders of Marrow Failure". The Oncologist. 19 (7): 735–745. doi:10.1634/theoncologist.2014-0056. ISSN 1083-7159.

[WeinzierlArber2012-4] Weinzierl, E. P.; Arber, D. A. (2012). "The Differential Diagnosis and Bone Marrow Evaluation of New-Onset Pancytopenia". American Journal of Clinical Pathology. 139 (1): 9–29. doi:10.1309/AJCP50AEEYGREWUZ. ISSN 0002-9173.

[pmid25663227-5] Koike H, Takahashi M, Ohyama K, Hashimoto R, Kawagashira Y, Iijima M, Katsuno M, Doi H, Tanaka F, Sobue G (March 2015). "Clinicopathologic features of folate-deficiency neuropathy". Neurology. 84 (10): 1026–33. doi:10.1212/WNL.0000000000001343. PMID 25663227.

[pmid25189324-6] Hunt A, Harrington D, Robinson S (September 2014). "Vitamin B12 deficiency". BMJ. 349: g5226. PMID 25189324.

[pmid25757096-7] Grohmann K, Lauffer H, Lauenstein P, Hoffmann GF, Seidlitz G (April 2015). "Hereditary orotic aciduria with epilepsy and without megaloblastic anemia". Neuropediatrics. 46 (2): 123–5. doi:10.1055/s-0035-1547341. PMID 25757096.

[pmid25455269-8] Alter BP (2014). "Fanconi anemia and the development of leukemia". Best Pract Res Clin Haematol. 27 (3–4): 214–21. doi:10.1016/j.beha.2014.10.002. PMC 4254647. PMID 25455269.

[pmid24665981-9] Vlachos A, Blanc L, Lipton JM (June 2014). "Diamond Blackfan anemia: a model for the translational approach to understanding human disease". Expert Rev Hematol. 7 (3): 359–72. doi:10.1586/17474086.2014.897923. PMID 24665981.

[pmid23953338-10] Marks PW (July 2013). "Hematologic manifestations of liver disease". Semin. Hematol. 50 (3): 216–21. doi:10.1053/j.seminhematol.2013.06.003. PMID 23953338.

[pmid24588059-11] Yokoyama A, Yokoyama T, Brooks PJ, Mizukami T, Matsui T, Kimura M, Matsushita S, Higuchi S, Maruyama K (May 2014). "Macrocytosis, macrocytic anemia, and genetic polymorphisms of alcohol dehydrogenase-1B and aldehyde dehydrogenase-2 in Japanese alcoholic men". Alcohol. Clin. Exp. Res. 38 (5): 1237–46. doi:10.1111/acer.12372. PMID 24588059.

[NatelsonPyatt2013-12] Natelson, Ethan A.; Pyatt, David (2013). "Acquired Myelodysplasia or Myelodysplastic Syndrome: Clearing the Fog". Advances in Hematology. 2013: 1–11. doi:10.1155/2013/309637. ISSN 1687-9104.

[TownsleyDesmond2013-13] Townsley, Danielle M.; Desmond, Ronan; Dunbar, Cynthia E.; Young, Neal S. (2013). "Pathophysiology and management of thrombocytopenia in bone marrow failure: possible clinical applications of TPO receptor agonists in aplastic anemia and myelodysplastic syndromes". International Journal of Hematology. 98 (1): 48–55. doi:10.1007/s12185-013-1352-6. ISSN 0925-5710.

[OshimaYuji2013-14] Oshima, Yasuo; Yuji, Koichiro; Tanimoto, Tetsuya; Hinomura, Yasushi; Tojo, Arinobu (2013). "Association between Acute Myelogenous Leukemia and Thrombopoietin Receptor Agonists in Patients with Immune Thrombocytopenia". Internal Medicine. 52 (19): 2193–2201. doi:10.2169/internalmedicine.52.0324. ISSN 0918-2918.

[pmid24088751-15] Oshima Y, Yuji K, Tanimoto T, Hinomura Y, Tojo A (2013). "Association between acute myelogenous leukemia and thrombopoietin receptor agonists in patients with immune thrombocytopenia". Intern. Med. 52 (19): 2193–201. PMID 24088751.

[pmid25237200-16] Brodsky RA (2014). "Paroxysmal nocturnal hemoglobinuria". Blood. 124 (18): 2804–11. doi:10.1182/blood-2014-02-522128. PMC 4215311. PMID 25237200.

[pmid22986360-17] Noris M, Mescia F, Remuzzi G (November 2012). "STEC-HUS, atypical HUS and TTP are all diseases of complement activation". Nat Rev Nephrol. 8 (11): 622–33. doi:10.1038/nrneph.2012.195. PMID 22986360.

[pmid26396094-18] Conway EM (October 2015). "HUS and the case for complement". Blood. 126 (18): 2085–90. doi:10.1182/blood-2015-03-569277. PMID 26396094.

[pmid25503977-19] Schwameis M, Schörgenhofer C, Assinger A, Steiner MM, Jilma B (April 2015). "VWF excess and ADAMTS13 deficiency: a unifying pathomechanism linking inflammation to thrombosis in DIC, malaria, and TTP". Thromb. Haemost. 113 (4): 708–18. doi:10.1160/TH14-09-0731. PMC 4745134. PMID 25503977.

[pmid20008204-20] Kitchens CS (2009). "Thrombocytopenia and thrombosis in disseminated intravascular coagulation (DIC)". Hematology Am Soc Hematol Educ Program: 240–6. doi:10.1182/asheducation-2009.1.240. PMID 20008204.

[ClarkeWeston-Smith2010-21] Clarke, V.; Weston-Smith, S. (2010). "Severe folate-deficiency pancytopenia". Case Reports. 2010 (oct18 2): bcr0320102851–bcr0320102851. doi:10.1136/bcr.03.2010.2851. ISSN 1757-790X.

[pmid23069991-22] Blackmer AB, Bailey E (February 2013). "Management of copper deficiency in cholestatic infants: review of the literature and a case series". Nutr Clin Pract. 28 (1): 75–86. doi:10.1177/0884533612461531. PMID 23069991.

[pmid22726100-23] Nurden AT, Freson K, Seligsohn U (2012). "Inherited platelet disorders". Haemophilia. 18 Suppl 4: 154–60. doi:10.1111/j.1365-2516.2012.02856.x. PMID 22726100.

[BalduiniSavoia2012-24] Balduini, Carlo L.; Savoia, Anna (2012). "Genetics of familial forms of thrombocytopenia". Human Genetics. 131 (12): 1821–1832. doi:10.1007/s00439-012-1215-x. ISSN 0340-6717.

[pmid20011639-25] D'Andrea G, Chetta M, Margaglione M (2009). "Inherited platelet disorders: thrombocytopenias and thrombocytopathies". Blood Transfus. 7 (4): 278–92. doi:10.2450/2009.0078-08. PMC 2782805. PMID 20011639.

[pmid24643058-26] Zhang S, Zhou X, Liu S, Bai T, Zhang Y, Wang J, Wang S, Zhang X, Wang B (2014). "MYH9-related disease: description of a large Chinese pedigree and a survey of reported mutations". Acta Haematol. 132 (2): 193–8. doi:10.1159/000356681. PMID 24643058.

[pmid21357716-27] Berndt MC, Andrews RK (March 2011). "Bernard-Soulier syndrome". Haematologica. 96 (3): 355–9. doi:10.3324/haematol.2010.039883. PMC 3046265. PMID 21357716.

[pmid23427340-28] Michelson AD (January 2013). "Gray platelet syndrome". Blood. 121 (2): 250. PMID 23427340.

[pmid29086100-29] Candotti F (January 2018). "Clinical Manifestations and Pathophysiological Mechanisms of the Wiskott-Aldrich Syndrome". J. Clin. Immunol. 38 (1): 13–27. doi:10.1007/s10875-017-0453-z. PMID 29086100.

[pmid27981927-30] Al-Qattan MM (November 2016). "The Pathogenesis of Radial Ray Deficiency in Thrombocytopenia-Absent Radius (TAR) Syndrome". J Coll Physicians Surg Pak. 26 (11): 912–916. doi:2476 Check |doi= value (help). PMID 27981927.

[pmid10577925-31] Toren A, Amariglio N, Rozenfeld-Granot G, Simon AJ, Brok-Simoni F, Pras E, Rechavi G (December 1999). "Genetic linkage of autosomal-dominant Alport syndrome with leukocyte inclusions and macrothrombocytopenia (Fechtner syndrome) to chromosome 22q11-13". Am. J. Hum. Genet. 65 (6): 1711–7. doi:10.1086/302654. PMC 1288382. PMID 10577925.

[pmid24337418-32] Langer F, Obser T, Oyen F, Spath B, Holstein K, Greinacher A, White JG, Budde U, Bokemeyer C, Schneppenheim R (April 2014). "Characterisation of the p.A1461D mutation causing von Willebrand disease type 2B with severe thrombocytopenia, circulating giant platelets, and defective α-granule secretion". Thromb. Haemost. 111 (4): 777–9. doi:10.1160/TH13-06-0462. PMID 24337418.

[ZuffereyKapur2017-33] Zufferey, Anne; Kapur, Rick; Semple, John (2017). "Pathogenesis and Therapeutic Mechanisms in Immune Thrombocytopenia (ITP)". Journal of Clinical Medicine. 6 (2): 16. doi:10.3390/jcm6020016. ISSN 2077-0383.

[pmid27777394-34] Abu-Hishmeh M, Sattar A, Zarlasht F, Ramadan M, Abdel-Rahman A, Hinson S, Hwang C (October 2016). "Systemic Lupus Erythematosus Presenting as Refractory Thrombotic Thrombocytopenic Purpura: A Diagnostic and Management Challenge. A Case Report and Concise Review of the Literature". Am J Case Rep. 17: 782–787. PMC 5083062. PMID 27777394.

[Artim-EsenDiz-Küçükkaya2015-35] Artim-Esen, Bahar; Diz-Küçükkaya, Reyhan; İnanç, Murat (2015). "The Significance and Management of Thrombocytopenia in Antiphospholipid Syndrome". Current Rheumatology Reports. 17 (3). doi:10.1007/s11926-014-0494-8. ISSN 1523-3774.

[ChavalitdhamrongMolovic-Kokovic2009-36] Chavalitdhamrong, Disaya; Molovic-Kokovic, Ana; Iliev, Andrey (2009). "Felty's Syndrome as an initial presentation of Rheumatoid Arthritis: a case report". Cases Journal. 2 (1): 206. doi:10.1186/1757-1626-2-206. ISSN 1757-1626.

[WuRen2014-37] Wu, Qin; Ren, Jianan; Wu, Xiuwen; Wang, Gefei; Gu, Guosheng; Liu, Song; Wu, Yin; Hu, Dong; Zhao, Yunzhao; Li, Jieshou (2014). "Recombinant human thrombopoietin improves platelet counts and reduces platelet transfusion possibility among patients with severe sepsis and thrombocytopenia: A prospective study". Journal of Critical Care. 29 (3): 362–366. doi:10.1016/j.jcrc.2013.11.023. ISSN 0883-9441.

[pmid24574745-38] Kuwana M (January 2014). "Helicobacter pylori-associated immune thrombocytopenia: clinical features and pathogenic mechanisms". World J. Gastroenterol. 20 (3): 714–23. doi:10.3748/wjg.v20.i3.714. PMC 3921481. PMID 24574745.

[pmid24837566-39] Liu Q, He B, Huang SY, Wei F, Zhu XQ (August 2014). "Severe fever with thrombocytopenia syndrome, an emerging tick-borne zoonosis". Lancet Infect Dis. 14 (8): 763–772. doi:10.1016/S1473-3099(14)70718-2. PMID 24837566.

[pmid26098601-40] Borges ÁH, Lundgren JD, Mocroft A (July 2015). "Thrombocytopenia and cancer risk during HIV infection". AIDS. 29 (11): 1425–7. doi:10.1097/QAD.0000000000000744. PMID 26098601.

[pmid25518779-41] Saeed M, Dabbagh O, Al-Muhaizae M, Dhalaan H, Chedrawi A (November 2014). "Acute disseminated encephalomyelitis and thrombocytopenia following Epstein-Barr virus infection". J Coll Physicians Surg Pak. 24 Suppl 3: S216–8. doi:11.2014/JCPSP.S216S218 Check |doi= value (help). PMID 25518779.

[pmid25131143-42] Rodriguez-Morales AJ, Giselle-Badillo A, Manrique-Castaño S, Yepes MC (2014). "Anemia and thrombocytopenia in Plasmodium vivax malaria is not unusual in patients from endemic and non-endemic settings". Travel Med Infect Dis. 12 (5): 549–50. doi:10.1016/j.tmaid.2014.07.006. PMID 25131143.

[pmid24783256-43] Nackos E, DeSancho M (March 2014). "Anemia and thrombocytopenia: diagnosis from the blood smear". Blood. 123 (12): 1783. PMID 24783256.

[pmid17666285-44] Visentin GP, Liu CY (August 2007). "Drug-induced thrombocytopenia". Hematol. Oncol. Clin. North Am. 21 (4): 685–96, vi. doi:10.1016/j.hoc.2007.06.005. PMC 1993236. PMID 17666285.

[Lovecchio2014-45] Lovecchio, F. (2014). "Heparin-induced thrombocytopenia". Clinical Toxicology. 52 (6): 579–583. doi:10.3109/15563650.2014.917181. ISSN 1556-3650.

[ParameswaranLunning2014-46] Parameswaran, R.; Lunning, M.; Mantha, S.; Devlin, S.; Hamilton, A.; Schwartz, G.; Soff, G. (2014). "Romiplostim for management of chemotherapy-induced thrombocytopenia". Supportive Care in Cancer. 22 (5): 1217–1222. doi:10.1007/s00520-013-2074-2. ISSN 0941-4355.

[pmid23233625-47] Bercovitz RS, Josephson CD (2012). "Thrombocytopenia and bleeding in pediatric oncology patients". Hematology Am Soc Hematol Educ Program. 2012: 499–505. doi:10.1182/asheducation-2012.1.499. PMID 23233625.

[LoffredoVioli20182-48] Loffredo, Lorenzo; Violi, Francesco (2018). "Thrombopoietin receptor agonists and risk of portal vein thrombosis in patients with liver disease and thrombocytopenia: A meta-analysis". Digestive and Liver Disease. doi:10.1016/j.dld.2018.06.005. ISSN 1590-8658.

[pmid17729421-49] Jia YP, Lu Q, Gong S, Ma BY, Wen XR, Peng YL, Lin L, Chen HY, Qiu L, Luo Y (September 2007). "Postoperative complications in patients with portal vein thrombosis after liver transplantation: evaluation with Doppler ultrasonography". World J. Gastroenterol. 13 (34): 4636–40. PMC 4611842. PMID 17729421.

[50] Lewis D, Vaidya R. Kasabach Merritt Syndrome. [Updated 2018 Jul 27]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2018 Jan-. Available from: https://www-ncbi-nlm-nih-gov.ezp-prod1.hul.harvard.edu/books/NBK519053/

[VinodJohny2017-51] Vinod, Kolar Vishwanath; Johny, Joseph; Vadivelan, Mehalingam; Hamide, Abdoul (2017). "Kasabach-Merritt Syndrome in an adult". Turkish Journal of Hematology. doi:10.4274/tjh.2017.0429. ISSN 1300-7777.

[JiKim2015-52] Ji, Sung-Mi; Kim, Sung-Hoon; Nam, Jae-Sik; Yun, Hye-Joo; Choi, Jeong-Hyun; Lee, Eun-Ho; Choi, In-Cheol (2015). "Predictive value of rotational thromboelastometry during cardiopulmonary bypass for thrombocytopenia and hypofibrinogenemia after weaning of cardiopulmonary bypass". Korean Journal of Anesthesiology. 68 (3): 241. doi:10.4097/kjae.2015.68.3.241. ISSN 2005-6419.

[pmid15100613-53] Latvala J, Parkkila S, Niemelä O (April 2004). "Excess alcohol consumption is common in patients with cytopenia: studies in blood and bone marrow cells". Alcohol. Clin. Exp. Res. 28 (4): 619–24. PMID 15100613.

[McCraeHerman1996-54] McCrae, Keith R.; Herman, Jay H. (1996). "Posttransfusion purpura: Two unusual cases and a literature review". American Journal of Hematology. 52 (3): 205–211. doi:10.1002/(SICI)1096-8652(199607)52:3<205::AID-AJH13>3.0.CO;2-E. ISSN 0361-8609.

[PavenskiWebert2008-55] Pavenski, Katerina; Webert, Kathryn E.; Goldman, Mindy (2008). "Consequences of transfusion of platelet antibody: a case report and literature review". Transfusion. 48 (9): 1981–1989. doi:10.1111/j.1537-2995.2008.01796.x. ISSN 0041-1132.

[ReesePeck2018-56] Reese, Jessica A.; Peck, Jennifer D.; Deschamps, David R.; McIntosh, Jennifer J.; Knudtson, Eric J.; Terrell, Deirdra R.; Vesely, Sara K.; George, James N. (2018). "Platelet Counts during Pregnancy". New England Journal of Medicine. 379 (1): 32–43. doi:10.1056/NEJMoa1802897. ISSN 0028-4793.

[Barnhart2015-57] Barnhart, Lynette (2015). "HELLP Syndrome and the Effects on the Neonate". Neonatal Network. 34 (5): 269–273. doi:10.1891/0730-0832.34.5.269. ISSN 0730-0832.

[HaramSvendsen2009-58] Haram, Kjell; Svendsen, Einar; Abildgaard, Ulrich (2009). "The HELLP syndrome: Clinical issues and management. A Review". BMC Pregnancy and Childbirth. 9 (1). doi:10.1186/1471-2393-9-8. ISSN 1471-2393.

[Go2005-59] Go, Ronald S. (2005). "Idiopathic cyclic thrombocytopenia". Blood Reviews. 19 (1): 53–59. doi:10.1016/j.blre.2004.05.001. ISSN 0268-960X.

[TanStalling2016-60] Tan, Geok Chin; Stalling, Melissa; Dennis, Gretchen; Nunez, Maria; Kahwash, Samir B. (2016). "Pseudothrombocytopenia due to Platelet Clumping: A Case Report and Brief Review of the Literature". Case Reports in Hematology. 2016: 1–4. doi:10.1155/2016/3036476. ISSN 2090-6560.

[1]

[2]

[3]

[4]

[5]

[6]

[7]

[8]

[9]

[10]

[11]

[12]

[13]

[14]

[15]

[16]

[17]

[18]

[19]

[20]

[21]

[22]

[23]

[24]

[25]

[26]

[27]

[28]

[29]

[30]

[31]

[32]

[33]

[34]

[35]

[36]

[37]

[38]

[39]

[40]

[41]

[42]

[43]

[44]

[45]

[46]

[47]

[48]

[49]

[50]

[51]

[52]

[53]

[54]

[55]

[56]

[57]

[58]

[59]

[60]

Myelodysplastic syndrome differential diagnosis

Overview

Myelodysplastic syndrome differential diagnosis

References

Navigation menu